Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral…
Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution
- Published
- 14 Oct 2026
- Units affected
- N/A
- Agency
- FDA
- Country
- United States
The hazard
Failed Impurities/Degradation Specifications
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by: Cipla Ltd., Kurkumbh-413802, Maharashtra, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-579-67.
- Brand / company
- Cipla USA, Inc.
- Codes / lots
- Lot#: 5KA0405, Exp 12/31/2026.
- Distribution
- USA Nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 14 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.